Dubai-based healthcare company Shalina has acquired Provexa Pharma Kenya Limited for an undisclosed price, adding to the flurry of acquisitions that have recently been recorded in Kenya’s pharmaceutical sector.
The competition watchdog on Monday gave Shalina Healthcare the greenlight to acquire all the issued issues of Provexa, a local wholesale distributor of cheap generic drugs, giving it a foothold in what is turning into a highly competitive sector.
